Stockreport

UPDATE 2-Novartis begins tender offer for cancer-focused MorphoSys [Yahoo! Finance]

MorphoSys AG - American Depositary Shares  (MOR) 
PDF German developer of cancer treatments, for an aggregate 2.7 billion euros ($2.9 billion). Reuters reported in February that Swiss drugmaker Novartis would buy MorphoSy [Read more]